Hexarelin 5mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided.

For research use only — not for human or veterinary use.

Product Overview

Hexarelin is a synthetic hexapeptide studied in controlled laboratory environments for its interaction with ghrelin-associated receptor systems and broader endocrine signalling cascades. This lyophilized 5 mg preparation is supplied in a sealed research vial and is intended exclusively for in vitro experimental applications.

Scientific Background

Hexarelin belongs to a class of receptor-active peptides investigated since the 1990s for their ability to interact with specific membrane-bound signalling systems. Within laboratory models, it is utilised to examine receptor-binding dynamics, intracellular cascade activation patterns and feedback-regulated endocrine pathway behaviour.

Its defined molecular structure and consistent analytical profile make it suitable for comparative signalling research under tightly controlled experimental conditions.

Research Context

Research into receptor-active peptides expanded significantly during the late twentieth century as laboratories explored peptide-mediated communication between neuroendocrine signalling centres and peripheral regulatory systems. Hexarelin has since been incorporated into experimental frameworks investigating signal amplification, pathway modulation and receptor-selective interaction modelling.

Mechanistic Focus in Research

• Ghrelin-receptor interaction analysis
• Endocrine signalling cascade modelling
• Receptor activation and feedback-loop research
• Comparative structure–function evaluation
• Controlled in vitro biochemical investigations

Analytical Verification (COA)

Independent Liquilabs analysis confirms validation for Batch GF122025097. Key analytical results include:

• Assay Content: 5.41 mg
• Identification – Retention Time: 0.995
• Identification – Spectrum: 994
• Purity: 99.7 percent
• Endotoxins: less than 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected
• Heavy Metals: not detected including arsenic, cadmium, cobalt, lead, nickel, mercury and vanadium

All analytical values were obtained using validated chromatographic, spectroscopic and microbiological procedures. Results relate only to the tested sample batch.

Research Applications

• Receptor-binding and activation modelling
• Endocrine signalling pathway analysis
• Pulsatile communication system research
• Comparative peptide evaluation
• Controlled laboratory investigations

Grail Formula Quality

Each Grail Formula research peptide undergoes independent third-party laboratory verification for identity, assay content, purity and microbial safety. This ensures analytical transparency, batch traceability and reproducibility for scientific research.

When You Choose Grail Formula…

Researchers receive fully documented peptide materials with sealed-vial integrity and independent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment
• Supplied for human investigational use

Independently verified by Liquilabs s.r.o. (Czechia)
Validated assay content 5.41 mg
Confirmed purity 99.7 percent
Retention time and spectral identity confirmation
Endotoxin levels below 0.001 EU per mg
No detectable microbial contamination
No detectable heavy metals
EU shipments include bacteriostatic water
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.